Calan Sowa, MD
Sports Medicine · New Britain, CTNPI 1164954905
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $988 of the $1,485 with a category attached, or 66.5%. Pacira Pharmaceuticals Incorporated accounts for 74.7% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2024 at $1,092 and has fallen 96.8% since, to $35 in 2025. That places this record below the midpoint for sports medicine clinicians in CT, where the typical reported total is $1,485.
Across 19 payments — averaging $78.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pacira Pharmaceuticals Incorporated$1K
- Arthrex$150
- Johnson & Johnson$83
- Orthofix Medical, Inc.$54
- Bioventus LLC$33
- Sanofi-aventis U.S. LLC$21
- plus $35 from 2 others
What the payments were for
- Travel & lodging$98867%
- Food & beverage$49733%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pacira Pharmaceuticals Incorporated | 9 | $1,110 |
| Arthrex | 1 | $150 |
| Johnson & Johnson | 3 | $83 |
| Orthofix Medical, Inc. | 2 | $54 |
| Bioventus LLC | 1 | $33 |
| Sanofi-aventis U.S. LLC | 1 | $21 |
| Coastal Technology Solutions LLC | 1 | $18 |
| Smith+Nephew | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,485 in reported general payments places this provider in the 50th percentile of 65 sports medicine providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 83 | $2,189 |
| Methylprednisolone | 122 | $816 |
| Meloxicam | 280 | $445 |
| Cyclobenzaprine Hcl | 28 | $128 |
| Prednisone | 45 | $105 |
| Ibuprofen | 20 | $82 |
| Gabapentin | 13 | $68 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in New Britain
- Robert BelniakNew Britain$10K
- Augustus MazzoccaFarmington$1M
- Michael KaplanMiddlebury$385K
- Robert ArcieroFarmington$269K
- Karen SuttonStamford$245K
- Michael KuhnMiddletown$201K
- Katherine CoynerFarmington$186K
- Joshua FrankNorwalk$78K
- Michael JoyceGlastonbury$73K
- Andrew JimenezNew Haven$66K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.